atma cena logo
Book Info Call
Explore PAT Training

Psychedelics 101

Understanding Entheogenic Medicine
Book an Info Call

What Are Psychedelics?

Psychedelic compounds are a class of psychoactive substances that alter perception, mood, and cognitive processes by primarily interacting with serotonin receptors in the brain. These molecules have been used for thousands of years in traditional medicine and spiritual practices across cultures worldwide, and are now the subject of intensive scientific research for their therapeutic potential. While often grouped together as “psychedelics,” these compounds represent diverse chemical families with distinct molecular structures, mechanisms of action, duration of effects, and experiential qualities. Understanding the unique properties of each medicine helps inform safe, effective therapeutic applications.

In the mid-20th century, psychedelics entered Western consciousness primarily through the work of researchers like Albert Hofmann, who synthesized LSD, and R. Gordon Wasson, who documented the use of psilocybin mushrooms in Mexico. The 1960s saw a surge of interest in psychedelics, both in scientific research and popular culture. However, due to political and social backlash, psychedelics were criminalized in the 1970s, halting most research.

In recent decades, there has been a resurgence of interest in the therapeutic potential of psychedelics. Modern studies are building on ancient wisdom and mid-20th century research, showing promising results for a range of mental health conditions. This revival is paving the way for a new era of psychedelic-assisted therapy, bringing these ancient tools into contemporary clinical practice.

Psychedelic Therapy Clinic in Edmonton

What Are Psychedelic Molecules?

Psychedelic compounds are a diverse class of psychoactive substances that have been used for thousands of years in traditional healing practices and spiritual ceremonies across cultures worldwide. These molecules work primarily by interacting with serotonin receptors in the brain, creating profound shifts in perception, emotion, and consciousness. While often grouped together under the umbrella term “psychedelics,” these compounds actually represent several distinct chemical families, each with unique molecular structures, mechanisms of action, and experiential qualities. The major classes include tryptamines—which are structurally similar to serotonin and include compounds naturally found in certain mushroom species as well as DMT and 5-MeO-DMT from various plant sources—phenethylamines like mescaline from sacred cacti and empathogen-entactogens that produce emotional openness and empathy, and dissociative anesthetics that work through different brain mechanisms to create feelings of detachment and perspective shifts. There are also atypical psychedelics like ibogaine from African root bark, known particularly for treating addiction, and salvinorin A, which works through entirely unique pathways in the brain.

Understanding the differences between these compound classes is essential because each offers distinct therapeutic applications and requires different safety considerations. Tryptamines tend to produce visual alterations, emotional openness, and philosophical insights over a four-to-six-hour period, making them well-suited for addressing depression, anxiety, and existential distress. Empathogen-entactogens create states of emotional openness while maintaining mental clarity, which has proven particularly effective for processing trauma and facilitating therapeutic breakthroughs in PTSD treatment. Dissociative compounds offer rapid-acting relief from treatment-resistant depression and can facilitate dramatic perspective shifts through their unique mechanism of blocking certain receptors rather than activating them. The choice of which compound to work with depends on individual therapeutic goals, medical history, psychological readiness, and the specific condition being addressed. At ATMA CENA, our clinical team is trained in the unique properties and applications of each medicine class and works closely with clients to determine the most appropriate compound for their healing journey.

 

How Psychedelic Compounds Work in the Brain

The therapeutic power of psychedelic medicines lies in their ability to create temporary but profound changes in brain function that can catalyze lasting psychological transformation. Most classic psychedelics exert their primary effects by binding to and activating serotonin 2A receptors, particularly in the prefrontal cortex and other regions involved in perception, emotion, and cognition. This receptor activation triggers a cascade of neurobiological effects including increased communication between brain regions that don’t normally interact, temporary disruption of the default mode network responsible for self-referential thinking and ego maintenance, enhanced neuroplasticity that allows the brain to form new neural connections and break free from rigid patterns, and modulation of various neurotransmitter systems that regulate mood and emotional processing. Neuroimaging studies using fMRI and other technologies have revealed that psychedelics don’t simply activate the brain randomly—rather, they create highly organized states of “controlled chaos” where increased entropy and cross-talk between brain networks allows for novel perspectives, emotional breakthroughs, and the dissolution of maladaptive thought patterns that underlie many mental health conditions.


The concept of neuroplasticity is central to understanding psychedelic therapy’s lasting benefits. These compounds promote the growth of new dendritic branches and synaptic connections, essentially allowing the brain to rewire itself during and after the psychedelic experience. This enhanced plasticity creates what researchers call a “critical period”—a window of heightened malleability similar to developmental stages in childhood when the brain is most receptive to new learning and pattern formation. During this critical period, which can last for days or weeks after a psychedelic session, individuals are more capable of breaking old habits, processing traumatic memories without overwhelming distress, forming new perspectives on long-standing problems, and integrating insights into lasting behavioral changes. This is why the integration phase following a psychedelic experience is so crucial—the medicines open a window of opportunity, but it’s the therapeutic work done during this enhanced plasticity period that determines whether temporary insights become permanent transformation. The neuroplasticity effects help explain why psychedelic therapy can produce rapid, substantial improvements in conditions like depression and PTSD that might otherwise require years of conventional treatment, and why even a single session can sometimes catalyze changes that persist for months or years.

Safety, Research, and Therapeutic Applications

One of the most remarkable aspects of psychedelic compounds is their exceptional safety profile when used in controlled therapeutic settings. Classic psychedelics have remarkably low physiological toxicity with no known fatal overdoses, minimal impact on organ systems, and no potential for physical dependence—in fact, many show anti-addictive properties. The primary risks are psychological, including challenging experiences and the theoretical risk of triggering latent conditions in predisposed individuals, which are effectively mitigated through comprehensive screening, careful dosing, and professional support. Certain medical conditions and medication interactions require caution, particularly with cardiovascular issues and psychiatric medications like SSRIs or lithium, making thorough medical screening essential.

 

The current renaissance in psychedelic research is producing compelling evidence across mental health conditions. Clinical trials show empathogen-entactogen therapy produces lasting PTSD symptom reductions, tryptamine-based therapy demonstrates rapid improvements in treatment-resistant depression and end-of-life anxiety, and various compounds show promise for addiction treatment. What makes these results especially compelling is their durability—benefits from one or few sessions often persist for months or years, with many describing their experiences as among the most meaningful of their lives.

 

In Canada, the legal landscape is evolving rapidly. While most psychedelic compounds remain controlled substances, Health Canada has been granting exemptions for compassionate use, research trials, practitioner training, and individual patient access. ATMA CENA operates within all regulations and works to provide legal access for eligible clients. As research demonstrates safety and efficacy, we anticipate continued regulatory evolution toward broader therapeutic access.

Why Psychedelics are Effective in Therapy

Psychedelics are unique in their ability to enhance therapeutic outcomes by promoting deep emotional and cognitive insights. Psychedelic- assisted Therapy (PaT) can help individuals access repressed memories, process unresolved trauma, and gain new perspectives on their lives. PaT creates a supportive environment for healing and personal growth. Here are some reasons why it is so effective:

Emotional Release & Insight

Psychedelics can facilitate the release of deep-seated emotions and traumas, allowing individuals to confront and process difficult experiences in a safe and supportive setting. This can lead to significant emotional breakthroughs and a greater understanding of one’s self and experiences.

Altered States of Consciousness

Psychedelics induce altered states of consciousness that can provide profound, transformative experiences. These experiences often lead to a sense of interconnectedness, spiritual insight, and a reevaluation of personal values and goals. Such shifts in perspective can be deeply therapeutic, helping individuals to find meaning and purpose in their lives.

Enhanced Therapeutic Alliance

The use of psychedelics in therapy can strengthen the bond between the therapist and the client. Substances like MDMA promote feelings of trust, empathy, and openness, which can enhance the therapeutic relationship and create a more conducive environment for healing.

Reduced Fear Response

Psychedelics like MDMA have been shown to reduce activity in the amygdala, the brain region responsible for processing fear. This reduction in fear response can help individuals to confront traumatic memories without being overwhelmed, making it easier to process and integrate these experiences.

Neuroplasticity

One of the most exciting aspects of psychedelics is their ability to promote neuroplasticity, the brain’s capacity to reorganize itself by forming new neural connections. Psychedelics can enhance neuroplasticity, enabling individuals to break free from negative thought patterns and develop healthier, more adaptive ways of thinking. This increased neural flexibility is particularly beneficial for treating conditions like depression and PTSD, where rigid, maladaptive thought patterns often play a central role.

Lasting Positive Changes

The combination of psychedelic experiences and therapeutic guidance can lead to lasting positive changes in mental health and well-being. Many individuals report sustained improvements in mood, outlook, and overall quality of life following psychedelic-assisted therapy.

Educational articles & quotes

General

 

MDMA

 

Psilocybin

 

Ketamine